ATP citrate-lyase

nwamba # Aha ngwaahịa Nkọwa
CPD3611 SB-204990 SB-204990 bụ prodrug nke ike ATP citrate-lyase inhibitor SB-201076. SB-204990, mgbe a na-enye oke ọnụ ọnụ, etinyere ya na mgbasa ozi sistemu, a na-enwetakwa mkpokọta ọgwụ SB-201076 n'ime imeju. SB-204990 (25 mg / kg kwa ụbọchị) na-ebelata ọkwa cholesterol plasma (ruo 23%) na ọkwa triglyceride (ruo 38%) na nkịta, ọkacha mma na-ebelata lipoprotein dị ala ma e jiri ya tụnyere cholesterol lipoprotein dị elu. ọkwa. SB-204990 bụ enzyme dị mkpa n'ịchịkwa mkpụrụ maka njikọ lipid de novo yana ebumnuche enzyme nwere ike ime maka ntinye aka hypolipidemia.
nke

Kpọtụrụ anyị

Ajuju

Akụkọ kacha ọhụrụ

  • Usoro 7 kachasị na nyocha ọgwụ na 2018

    Usoro 7 kacha elu na nyocha ọgwụ m...

    N'ịbụ ndị nọ n'okpuru nrụgide na-arịwanye elu mgbe niile ịsọ mpi na gburugburu ebe obibi akụ na ụba na nkà na ụzụ siri ike, ụlọ ọrụ ọgwụ na biotech ga-anọgide na-emepe emepe na mmemme R&D ha iji nọgide na-aga n'ihu ...

  • ARS-1620: Onye mmechi ọhụrụ na-ekwe nkwa maka ọrịa cancer KRAS-mutant

    ARS-1620: ihe mgbochi ọhụrụ na-ekwe nkwa maka K…

    Dị ka otu nnyocha e bipụtara na Cell si kwuo, ndị nchọpụta ewepụtala ihe mgbochi kpọmkwem maka KRASG12C nke a na-akpọ ARS-1602 nke na-eme ka ụbụrụ tumor regression na ụmụ oke. "Ọmụmụ ihe a na-enye na vivo ihe akaebe na mutant KRAS nwere ike ịbụ ...

  • AstraZeneca na-enweta nkwalite nchịkwa maka ọgwụ oncology

    AstraZeneca na-enweta nkwalite nchịkwa maka ...

    AstraZeneca nwetara nkwalite okpukpu abụọ maka pọtụfoliyo oncology ya na Tuesday, mgbe ndị na-ahụ maka US na European nabatara ntinye iwu maka ọgwụ ya, nzọụkwụ mbụ iji nweta nkwado maka ọgwụ ndị a. ...

Mkparịta ụka WhatsApp n'ịntanetị!